{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:16:03Z","timestamp":1790363763094,"version":"4.1.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"US Department of Health and Human Services","doi-asserted-by":"publisher","award":["75A50120C00001)"],"award-info":[{"award-number":["75A50120C00001)"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Paratek Pharmaceuticals, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Streptococcus pneumoniae isolates from the United States (n = 1038; 2019\u20132021) were susceptible to omadacycline (99.8%), levofloxacin (99.7%), and ceftriaxone (98.1%), whereas doxycycline (80.2%), oral penicillin (63.5%), cefpodoxime (76.8%), and azithromycin (54.4%) activity was limited. Tet(M) did not affect omadacycline activity but altered activity of older tetracyclines including doxycycline, suggesting omadacycline is an important option for treatment of community-acquired bacterial pneumonia.<\/jats:p>","DOI":"10.1093\/ofid\/ofae470","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T18:32:00Z","timestamp":1724092320000},"source":"Crossref","is-referenced-by-count":9,"title":["High Rates of Nonsusceptibility to Common Oral Antibiotics in\n                    <i>Streptococcus pneumoniae<\/i>\n                    Clinical Isolates From the United States (2019\u20132021)"],"prefix":"10.1093","volume":"11","author":[{"given":"Lalitagauri M","family":"Deshpande","sequence":"first","affiliation":[{"name":"Element Iowa City (JMI Laboratories) , North Liberty, Iowa ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Huband","sequence":"additional","affiliation":[{"name":"Element Iowa City (JMI Laboratories) , North Liberty, Iowa ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Charbon","sequence":"additional","affiliation":[{"name":"Element Iowa City (JMI Laboratories) , North Liberty, Iowa ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Castanheira","sequence":"additional","affiliation":[{"name":"Element Iowa City (JMI Laboratories) , North Liberty, Iowa ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo E","family":"Mendes","sequence":"additional","affiliation":[{"name":"Element Iowa City (JMI Laboratories) , North Liberty, Iowa ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"2024092714525880300_ofae470-B1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jinf.2020.07.035","article-title":"Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009\u20122017","volume":"81","author":"Suaya","year":"2020","journal-title":"J Infect"},{"key":"2024092714525880300_ofae470-B2","doi-asserted-by":"crossref","first-page":"e735","DOI":"10.1016\/S2666-5247(22)00158-6","article-title":"Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study","volume":"3","author":"Lo","year":"2022","journal-title":"Lancet Microbe"},{"key":"2024092714525880300_ofae470-B3","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024092714525880300_ofae470-B4","author":"Centers for Disease Control and Prevention"},{"key":"2024092714525880300_ofae470-B5","doi-asserted-by":"crossref","first-page":"ofac420","DOI":"10.1093\/ofid\/ofac420","article-title":"A multicenter evaluation of trends in antimicrobial resistance among Streptococcus pneumoniae isolates from adults in the United States","volume":"9","author":"Mohanty","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2024092714525880300_ofae470-B6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/ciac615","article-title":"Efficacy of doxycycline for mild-to-moderate community-acquired pneumonia in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"76","author":"Choi","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024092714525880300_ofae470-B7","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/AAC.34.11.2075","article-title":"Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States","volume":"34","author":"Jorgensen","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"2024092714525880300_ofae470-B8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/infdis\/163.6.1273","article-title":"Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979\u20131987. The Pneumococcal Surveillance Working Group","volume":"163","author":"Spika","year":"1991","journal-title":"J Infect Dis"},{"key":"2024092714525880300_ofae470-B9","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"Clinical and Laboratory Standards Institute (CLSI).","year":"2018","edition":"11th ed"},{"key":"2024092714525880300_ofae470-B10","volume-title":"Performance standards for antimicrobial susceptibility testing. 33rd ed. CLSI supplement M100","author":"Clinical and Laboratory Standards Institute (CLSI).","year":"2023"},{"key":"2024092714525880300_ofae470-B11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"2024092714525880300_ofae470-B12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01242-13","article-title":"In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline","volume":"58","author":"Macone","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2024092714525880300_ofae470-B13","author":"Paratek Pharmaceuticals, Inc"},{"key":"2024092714525880300_ofae470-B14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/13696998.2021.1970974","article-title":"Comprehensive value assessments for new pediatric pneumococcal conjugate vaccines","volume":"24","author":"Hu","year":"2021","journal-title":"J Med Econ"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae470\/58888621\/ofae470.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/9\/ofae470\/59361465\/ofae470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/9\/ofae470\/59361465\/ofae470.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T10:53:12Z","timestamp":1727434392000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae470\/7738606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae470","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,22]]},"article-number":"ofae470"}}